BioNexus Gene Lab (BGLC) P/E (2020 - 2026)
BioNexus Gene Lab (BGLC) P/E from Sep 16, 2020 to Jul 21, 2026. The TTM BioNexus Gene Lab (BGLC) P/E is -1.15. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of BioNexus Gene Lab (BGLC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.15 | -55.96% |
| 2025 | -2.61 | -17.11% |
| 2024 | -3.14 | +3.84% |
| 2023 | -3.03 | -99.80% |
| 2022 | -1.49K | -411.41% |
| 2021 | 479.67 | +18.20% |
| 2020 | 405.82 | N/A |
Comparison BioNexus Gene Lab (BGLC) P/E with competitors
BioNexus Gene Lab (BGLC) P/E is -1.15.